Andersons pediatric cardiology 1668
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (60.59 KB, 3 trang )
cardiomyopathy:agenome-wideanalysis.JAm
CollCardiol.2010;55(11):1127–1135.
68.WangH,LiZ,WangJ,etal.Mutationsin
NEXN,aZ-discgene,areassociatedwith
hypertrophiccardiomyopathy.AmJHumGenet.
2010;87(5):687–693.
69.SantosS,MarquesV,PiresM,etal.High
resolutionmelting:improvementsinthegenetic
diagnosisofhypertrophiccardiomyopathyina
Portuguesecohort.BMCMedGenet.
2012;13:17.
70.HubyAC,MendsaikhanU,TakagiK,etal.
DisturbanceinZ-diskmechanosensitiveproteins
inducedbyapersistentmutantmyopalladin
causesfamilialrestrictivecardiomyopathy.JAm
CollCardiol.2014;64(25):2765–2776.
71.JensenMK,HavndrupO,ChristiansenM,etal.
Penetranceofhypertrophiccardiomyopathyin
childrenandadolescents:a12-yearfollow-up
studyofclinicalscreeningandpredictivegenetic
testing.Circulation.2013;127(1):48–54.
72.ElliottPM,D'CruzL,McKennaWJ.Late-onset
hypertrophiccardiomyopathycausedbya
mutationinthecardiactroponinTgene.NEngl
JMed.1999;341(24):1855–1856.
73.Ostman-SmithI,WettrellG,KeetonB,etal.
Age-andgender-specificmortalityratesin
childhoodhypertrophiccardiomyopathy.Eur
HeartJ.2008;29(9):1160–1167.
74.NiimuraH,BachinskiLL,SangwatanarojS,etal.
MutationsinthegeneforcardiacmyosinbindingproteinCandlate-onsetfamilial
hypertrophiccardiomyopathy.NEnglJMed.
1998;338(18):1248–1257.
75.Roma-RodriguesC,FernandesAR.Geneticsof
hypertrophiccardiomyopathy:advancesand
pitfallsinmoleculardiagnosisandtherapy.Appl
ClinGenet.2014;7:195–208.
76.LopesLR,ZekavatiA,SyrrisP,etal.Genetic
complexityinhypertrophiccardiomyopathy
revealedbyhigh-throughputsequencing.JMed
Genet.2013;50(4):228–239.
77.GirolamiF,HoCY,SemsarianC,etal.Clinical
featuresandoutcomeofhypertrophic
cardiomyopathyassociatedwithtriplesarcomere
proteingenemutations.JAmCollCardiol.
2010;55(14):1444–1453.
78.VanDriestSL,VasileVC,OmmenSR,etal.
MyosinbindingproteinCmutationsand
compoundheterozygosityinhypertrophic
cardiomyopathy.JAmCollCardiol.
2004;44(9):1903–1910.
79.FoureyD,CareM,SiminovitchKA,etal.
Prevalenceandclinicalimplicationofdouble
mutationsinhypertrophiccardiomyopathy:
revisitingtheGene-doseeffect.CircCardiovasc
Genet.2017;10(2).
80.MacArthurDG,BalasubramanianS,FrankishA,
etal.Asystematicsurveyofloss-of-function
variantsinhumanprotein-codinggenes.Science.
2012;335(6070):823–828.
81.PanS,CaleshuCA,DunnKE,etal.Cardiac
structuralandsarcomeregenesassociatedwith
cardiomyopathyexhibitmarkedintoleranceof
geneticvariation.CircCardiovascGenet.
2012;5(6):602–610.
82.LopesLR,MurphyC,SyrrisP,etal.Useofhighthroughputtargetedexome-sequencingtoscreen
forcopynumbervariationinhypertrophic
cardiomyopathy.EurJMedGenet.
2015;58(11):611–616.
83.WalshR,ThomsonKL,WareJS,etal.
Reassessmentofmendeliangenepathogenicity
using7,855cardiomyopathycasesand60,706
referencesamples.GenetMed.2017;19(2):192–
203.
84.DasKJ,InglesJ,BagnallRD,SemsarianC.
Determiningpathogenicityofgeneticvariantsin
hypertrophiccardiomyopathy:importanceof
periodicreassessment.GenetMed.
2014;16(4):286–293.
